Prestige Consumer Healthcare PBH North American OTC Healthcare — Contribution Margin

Similar metrics at other companies

EXLSNorth America — Gross Profit

$188.94M+16.7%

MATNorth America — Operating Income (Loss)

$34.49M-58.5%

MDLZNorth America — Operating Income (Loss)

$384M-20.8%

NSITNorth America — Gross Profit

$353.33M+10.6%

BCONorth America — Operating Income (Loss)

$60.9M+14.7%

INGMNorth America — Income from operations

$82.5M-2.2%

Questions, answered.

What is Prestige Consumer Healthcare's north american OTC healthcare — contribution margin?

Prestige Consumer Healthcare (PBH) reported north american OTC healthcare — contribution margin of $94.2M in Q1 2026.

How has Prestige Consumer Healthcare's north american OTC healthcare — contribution margin changed year-over-year?

Prestige Consumer Healthcare's north american OTC healthcare — contribution margin decreased by 15.7% year-over-year, from $111.69M to $94.2M.

What is the long-term trend for Prestige Consumer Healthcare's north american OTC healthcare — contribution margin?

Over 4 years (2022 to 2026), Prestige Consumer Healthcare's north american OTC healthcare — contribution margin has grown at a -1.9% compound annual growth rate (CAGR), from $410.01M to $380.03M.

What does north american OTC healthcare — contribution margin mean?

Represents the segment's revenue remaining after deducting both the cost of sales and direct advertising and marketing expenses. This metric isolates the core profitability of the product portfolio before the allocation of corporate overhead or shared administrative costs. It is a key measure of the operational efficiency and scalability of the North American consumer health business.